Aquestive Therapeutics, Inc. Amortization of Debt Issuance Costs
Aquestive Therapeutics, Inc. (AQST) reported Amortization of Debt Issuance Costs of $121.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-11
- Aquestive Therapeutics, Inc. amortization of debt issuance costs for the quarter ending 2026-06-30 was $61.00K, a 0.00% change year-over-year.
- Aquestive Therapeutics, Inc. amortization of debt issuance costs for the quarter ending 2026-03-31 was $60.00K, a 1.69% increase year-over-year.
- Aquestive Therapeutics, Inc. amortization of debt issuance costs for the quarter ending 2025-12-31 was $62.00K, a 1.64% increase year-over-year.
- Aquestive Therapeutics, Inc. amortization of debt issuance costs for the quarter ending 2025-09-30 was $61.00K, a 3.39% increase year-over-year.
- Aquestive Therapeutics, Inc. amortization of debt issuance costs for fiscal 2024 was $236.00K, a 7.27% increase from fiscal 2023.
- Aquestive Therapeutics, Inc. amortization of debt issuance costs for fiscal 2023 was $220.00K, a 5.77% increase from fiscal 2022.
- Aquestive Therapeutics, Inc. amortization of debt issuance costs for fiscal 2022 was $208.00K, a 30.82% increase from fiscal 2021.
- Aquestive Therapeutics, Inc. amortization of debt issuance costs for fiscal 2021 was $159.00K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 3 month as first filed | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 6 month as first filed | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 9 month as first filed | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $121.00K 10-Q · filed 2026-08-11 | $183.00K derived: sum of 3 quarters · filed 2026-08-11 | $244.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | $60.00K 10-Q · filed 2026-05-13 | $122.00K derived: sum of 2 quarters · filed 2026-08-11 | $183.00K derived: sum of 3 quarters · filed 2026-08-11 | $244.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | $62.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-11 | $123.00K derived: sum of 2 quarters · filed 2026-08-11 | $184.00K derived: sum of 3 quarters · filed 2026-08-11 | $243.00K 10-Q · filed 2026-08-11 | |||
| 2025-09-30 | $61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $122.00K derived: sum of 2 quarters · filed 2025-11-05 | $181.00K 10-Q · filed 2025-11-05 | $242.00K derived: sum of 4 quarters · filed 2026-03-04 | |||
| 2025-06-30 | $61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $120.00K 10-Q · filed 2025-08-11 | $181.00K derived: sum of 3 quarters · filed 2026-03-04 | $240.00K derived: sum of 4 quarters · filed 2026-03-04 | |||
| 2025-03-31 | $59.00K 10-Q · filed 2025-05-12 | $120.00K derived: sum of 2 quarters · filed 2026-03-04 | $179.00K derived: sum of 3 quarters · filed 2026-03-04 | $237.00K derived: sum of 4 quarters · filed 2026-03-04 | |||
| 2024-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $120.00K derived: sum of 2 quarters · filed 2026-03-04 | $178.00K derived: sum of 3 quarters · filed 2026-03-04 | $236.00K 10-K · filed 2026-03-04 | |||
| 2024-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $117.00K derived: sum of 2 quarters · filed 2024-11-04 | $175.00K 10-Q · filed 2024-11-04 | $175.00K derived: sum of 4 quarters · filed 2025-03-05 | |||
| 2024-06-30 | $58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $116.00K 10-Q · filed 2024-08-06 | $116.00K derived: sum of 3 quarters · filed 2025-03-05 | $116.00K derived: sum of 4 quarters · filed 2025-03-05 | |||
| 2024-03-31 | $58.00K 10-Q · filed 2024-05-07 | $58.00K derived: sum of 2 quarters · filed 2025-03-05 | $58.00K derived: sum of 3 quarters · filed 2025-03-05 | $58.00K derived: sum of 4 quarters · filed 2025-03-05 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $0.00 derived: sum of 2 quarters · filed 2025-03-05 | $0.00 derived: sum of 3 quarters · filed 2025-03-05 | $220.00K 10-K · filed 2025-03-05 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $0.00 derived: sum of 2 quarters · filed 2024-11-04 | $220.00K 10-Q · filed 2024-11-04 | $163.00K 10-Q · filed 2023-11-06 | $274.00K derived: sum of 4 quarters · filed 2024-11-04 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $220.00K 10-Q · filed 2024-08-06 | $107.00K 10-Q · filed 2023-08-07 | $274.00K derived: sum of 3 quarters · filed 2024-08-06 | $327.00K derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $220.00K 10-Q · filed 2024-05-07 | $52.00K 10-Q · filed 2023-05-02 | $274.00K derived: sum of 2 quarters · filed 2024-05-07 | $327.00K derived: sum of 3 quarters · filed 2024-05-07 | $378.00K derived: sum of 4 quarters · filed 2024-05-07 | ||
| 2022-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $107.00K derived: sum of 2 quarters · filed 2023-03-31 | $158.00K derived: sum of 3 quarters · filed 2023-03-31 | $208.00K 10-K · filed 2023-03-31 | |||
| 2022-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $104.00K derived: sum of 2 quarters · filed 2022-11-01 | $154.00K 10-Q · filed 2022-11-01 | $203.00K derived: sum of 4 quarters · filed 2022-11-01 | |||
| 2022-06-30 | $51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $101.00K 10-Q · filed 2022-08-02 | $150.00K derived: sum of 3 quarters · filed 2022-08-02 | $189.00K derived: sum of 4 quarters · filed 2022-08-02 | |||
| 2022-03-31 | $50.00K 10-Q · filed 2022-05-04 | $99.00K derived: sum of 2 quarters · filed 2022-05-04 | $138.00K derived: sum of 3 quarters · filed 2022-05-04 | ||||
| 2021-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $88.00K derived: sum of 2 quarters · filed 2022-03-08 | $159.00K 10-K · filed 2022-03-08 | ||||
| 2021-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $110.00K 10-Q · filed 2021-11-02 | |||||
| 2021-06-30 | $71.00K 10-Q · filed 2021-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |